Table 1. Details of patients who underwent treatment with yellow laser for central serous chorioretinopathy.
No | Age | Sex | Duration of follow-up (weeks) | Focal/diffuse leak | CDVA before laser | CDVA post laser | Lines of improvement | OCT fluid height before laser | OCT fluid height post laser | Reduction | Reduction |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 63 | M | 15 | Diffuse | 0.301 | 0.301 | 0 | 292 | 0 | 292 | 100% |
3 | 49 | M | 14 | Diffuse | 0.176 | 0.000 | 1 | 255 | 89 | 166 | 65% |
4 | 54 | M | 9 | Focal | 0.000 | 0.000 | 0 | 359 | 0 | 359 | 100% |
5 | 63 | M | 11 | Focal | 0.477 | 0.477 | 0 | 100 | 10 | 90 | 90% |
6 | 27 | M | 6 | Diffuse | 0.000 | 0.000 | 0 | 160 | 0 | 160 | 100% |
7 | 40 | M | 6 | Diffuse | 0.301 | 0.000 | 2 | 413 | 0 | 413 | 100% |
8 | 48 | M | 5 | Diffuse | 0.176 | 0.176 | 0 | 85 | 36 | 49 | 58% |
9 | 42 | M | 11 | Focal | 0.176 | 0.176 | 0 | 466 | 200 | 266 | 57% |
10 | 29 | M | 3 | Focal | 0.301 | 0.176 | 1 | 139 | 81 | 58 | 42% |
11 | 49 | M | 7 | Focal | 1.301 | 1.000 | 1 | 110 | 0 | 110 | 100% |
12 | 49 | M | 7 | Focal | 0.301 | 0.176 | 1 | 169 | 0 | 169 | 100% |
15 | 50 | M | 4 | Focal | 0.778 | 0.477 | 2 | 340 | 93 | 247 | 73% |
16 | 60 | M | 5 | Focal | 0.602 | 0.602 | 0 | 90 | 80 | 10 | 11% |
17 | 60 | M | 5 | Diffuse | 0.000 | 0.000 | 0 | 131 | 70 | 61 | 47% |
18 | 50 | F | 7 | Diffuse | 0.000 | 0.000 | 0 | 376 | 84 | 292 | 78% |
Average | 49 | 8 | 0.301 | 0.176 | 0 | 232 | 49.533 | 182.800 | 79% |